Karin Havenith

Biography

   Karin Havenith is Principal BioAnalytical Scientist at ADC Therapeutics. Dr. Havenith is experienced in the biotech industry, specialized in the development and validation of non-clinical and clinical bio-analytical assays, as well as CMC related bio-analytical assays for antibody-based therapeutics. Prior to joining ADC Therapeutics, Dr. Havenith was at Crucell Holland BV (Johnson & Johnson Company) as Biologicals Assay Manager for antibody-based therapeutics, and prior to Crucell she worked for more than seven years at Genmab, as Principal Scientist on cancer-target related antibody-based therapeutics. Prior to the biotech industry, Dr. Havenith spent more than 15 years in  academia at TNO Prevention & Health in Leiden, NL, St. Jude Children’s Hospital, Memphis TN, US, and Vrije University, Amsterdam, NL. Dr. Havenith graduated with her M.Sc. in Animal Husbandry from the University of Wageningen, NL, and obtained a Ph.D. in Cell Biology & Immunology from the Vrije University, Amsterdam, NL.  

Research Interest